| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.2 |